Tagayan, Rohaina M.

HRN: 17-39-89  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/15/2022
CEFUROXIME 1.5GM (VIAL)
10/15/2022
10/21/2022
IV
1.2g
Q8hours
UTI
Waiting Final Action 
10/15/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/15/2022
10/21/2022
IV
500mg
Q8hours
AGE With Moderate Dehydration
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: